IMAX Corporation (NYSE:IMAX – Get Free Report) was the target of some unusual options trading on Thursday. Stock traders purchased 3,458 call options on the company. This is an increase of approximately 241% compared to the average volume of 1,014 call options.
IMAX Stock Performance
IMAX opened at $43.21 on Friday. The company has a market cap of $2.38 billion, a price-to-earnings ratio of 60.02, a PEG ratio of 1.61 and a beta of 0.37. IMAX has a one year low of $24.20 and a one year high of $45.88. The business’s fifty day moving average is $39.99 and its two-hundred day moving average is $38.03.
IMAX (NYSE:IMAX – Get Free Report) last announced its quarterly earnings results on Thursday, July 23rd. The company reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.30 by $0.13. The business had revenue of $102.84 million during the quarter, compared to analysts’ expectations of $96.09 million. IMAX had a return on equity of 15.65% and a net margin of 9.84%.The business’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same quarter last year, the business posted $0.26 earnings per share. On average, analysts predict that IMAX will post 1.3 EPS for the current fiscal year.
Insider Activity
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the stock. Orbis Allan Gray Ltd grew its holdings in IMAX by 31.7% during the 2nd quarter. Orbis Allan Gray Ltd now owns 5,113,033 shares of the company’s stock valued at $142,960,000 after buying an additional 1,230,267 shares during the last quarter. Westfield Capital Management Co. LP raised its holdings in shares of IMAX by 44.6% in the fourth quarter. Westfield Capital Management Co. LP now owns 2,346,486 shares of the company’s stock worth $86,726,000 after acquiring an additional 723,861 shares during the last quarter. Marsico Capital Management LLC acquired a new position in shares of IMAX in the fourth quarter worth $18,149,000. Balyasny Asset Management L.P. purchased a new stake in shares of IMAX in the second quarter valued at $12,568,000. Finally, Nuveen LLC lifted its position in shares of IMAX by 253.0% in the fourth quarter. Nuveen LLC now owns 507,377 shares of the company’s stock valued at $18,753,000 after acquiring an additional 363,658 shares in the last quarter. 93.51% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on the stock. Barrington Research boosted their price objective on shares of IMAX from $46.00 to $50.00 and gave the company an “outperform” rating in a research note on Friday. JPMorgan Chase & Co. lifted their price target on IMAX from $47.00 to $50.00 and gave the company an “overweight” rating in a research note on Friday. Wells Fargo & Company boosted their target price on shares of IMAX from $41.00 to $45.00 and gave the stock an “equal weight” rating in a research report on Friday. Benchmark reiterated a “buy” rating on shares of IMAX in a report on Monday, June 22nd. Finally, Wedbush boosted their price objective on shares of IMAX from $46.00 to $54.00 and gave the stock an “outperform” rating in a report on Friday. Ten analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $50.36.
Read Our Latest Stock Report on IMAX
IMAX News Roundup
Here are the key news stories impacting IMAX this week:
- Positive Sentiment: IMAX reported better-than-expected second-quarter results, with EPS and revenue both topping Wall Street estimates, while management reaffirmed full-year guidance and highlighted margin expansion and network growth. IMAX Corporation Reports Second Quarter 2026 Results
- Positive Sentiment: Strong box-office traction for The Odyssey is boosting confidence that IMAX can sustain higher ticket sales and premium-screen utilization, with reports suggesting the film could be a transformational release for the company. The Odyssey is cleaning up for IMAX. Expect the momentum to continue
- Positive Sentiment: Analysts turned more bullish after earnings, with JPMorgan, Wells Fargo, Barrington, and Wedbush all raising price targets, and Wedbush reiterating Outperform on expectations for a stronger film pipeline, market-share gains, and international expansion. IMAX price target boosted by Wedbush on growth outlook
- Positive Sentiment: Investor attention is also being reinforced by unusual call-option activity and multiple stories about sold-out IMAX 70mm showings, signaling strong near-term demand sentiment around the stock. Imax’s CEO says it’s time to hike prices as tickets to ‘The Odyssey’ resell for $1,000
- Neutral Sentiment: IMAX disclosed a new regulatory risk tied to geopolitical, trade, and other global expansion challenges, which could matter over time but does not appear to be driving near-term trading. IMAX Confronts Rising Geopolitical, Regulatory and Trade Risks Threatening Global Expansion
About IMAX
IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.
Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.
Featured Stories
- Five stocks we like better than IMAX
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.
